We make antibodies for
fast-moving biopharmaceutical scientists.

We make antibodies for
fast-moving biopharmaceutical scientists.

Learn MoreDownload Our Catalog

June 17, 2019

Abveris Deploys the Berkeley Lights Beacon® Platform for Antibody Discovery

The Beacon platform enables rapid identification and isolation of antigen-specific antibody-secreting cells.

June 11, 2019

ABVERIS TO SPEAK AT FUTURE OF DRUG DISCOVERY AND DEVELOPMENT SYMPOSIUM

Ryan Kelly, Associate Director of BD, will give a talk at the Future of Drug Discovery and Development Symposium.

June 4, 2019

ABVERIS AND TETRAGENETICS ANNOUNCE ANTIBODY DISCOVERY COLLABORATION

Abveris, Inc. announced that it has entered into a multi-target agreement with TetraGenetics, Inc.

unnamed

Who we are

Antibody enthusiasts doing what we love.

graylogo

Science as a service.

At Abveris, we believe high-quality science is the most valuable deliverable to industry and academia. Therefore, we strive to provide exceptional antibody discovery services across the board, from early project design and communication to final product delivery.

graylogo

What's in a name?

The name “Abveris” is meant to serve as a daily reminder that excellence in science necessitates a commitment to scientific understanding. Inspired by the Harvard motto “veritas,” or “truth,” our name reaffirms the fact that discovery science is a constant quest for truth, and that “good data” is data with integrity.

graylogo

Our logo is dedicated to our home.

The Greater Boston community is a global beacon of scientific excellence. Our logo is inspired by the Zakim bridge, a modern, iconic landmark that erupts boldly from the Boston skyline. While the construction of the Zakim bridge is technologically advanced, it still pays homage to Boston’s historical revolutionary roots. Likewise, we strive to be a company that innovates boldly and probes boundaries while paying respect to the science and scientists whose achievements comprise our bedrock.

TESTIMONIALS

People Are Talking About Abveris

“We counted on Abveris to generate antibodies against a difficult target and we received numerous antibodies that resulted in several functional leads to progress a high priority program. Have seen similar results in subsequent projects. Abveris is an essential element to our research efforts.”

RAMESH BHATT

Head of Research & Co-Founder - Torch Therapeutics

“The team at Abveris was a pleasure to work with! They delivered a panel of antibodies that showed some mouse cross reactivity for a difficult target. They were able to stick to the aggressive timeline without compromising data quality.”

Senior Scientist

Boston Area Pharmaceutical Company

“Abveris provided excellent services for antibody discovery. The clear communication, project flexibility and final data package made the entire team a pleasure to work with.”

Scientist

Kanyos Bio

We’re certainly very happy with this work and the outcome, matching what we had hoped for at a crucial time for us... I look forward to continuing to work together in future.

Chris Paluch

Oxford University

KEEP IN TOUCH WITH OUR TEAM

Be the first to learn about exciting data and platform updates.

 

Over the past four years, we've grown in leaps and bounds.  We're constantly adding new service offerings and generating mounds of data for tough antibody targets. Join our mailing list, and you'll be the first to know when we have exciting new data and services to share.  

LEARN MORE ABOUT OUR SCIENCE

If you'd rather have a person-to-person discussion, we'd be happy to chat by phone, or even come visit your team at your lab. We'll fly anywhere in the world for our partners.

TALK TO A SCIENTIST

Ryan Cutout2